Literature DB >> 7648797

The genetic contribution to disease pathogenesis in childhood diabetes is greatest in the very young.

J P Shield1, E J Wadsworth, J D Baum.   

Abstract

Epidemiological data are presented to support the hypothesis that the genetic contribution to disease pathogenesis in childhood onset diabetes is greatest in those presenting at a very early age. Analysis of family data from two national surveys of childhood onset Type 1 (insulin-dependent) diabetes (1988 in under 15s: 1992 in under 5s) reveals that children developing diabetes between the ages 1 and 2 years are significantly more likely to have a parental history of Type 1 diabetes than older children. It is proposed that compared with other children, those with very early onset diabetes have either a greater genetic and smaller environmental contribution to the initiation of the autoimmune process leading to Type 1 diabetes: or inherited HLA alleles associated with a more fulminant autoimmune mediated Beta-cell destruction once the process is initiated.

Entities:  

Mesh:

Year:  1995        PMID: 7648797     DOI: 10.1111/j.1464-5491.1995.tb00498.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  4 in total

1.  Newborn HLA-DR,DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates.

Authors:  Lisa M Emery; Sunanda Babu; Teodorica L Bugawan; Jill M Norris; Henry A Erlich; George S Eisenbarth; Marian Rewers
Journal:  Pediatr Diabetes       Date:  2005-09       Impact factor: 4.866

2.  The role of HLA class I gene variation in autoimmune diabetes.

Authors:  Charles Sia; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2005-08-10

3.  Assessing age-related etiologic heterogeneity in the onset of islet autoimmunity.

Authors:  Brittni N Frederiksen; Miranda Kroehl; Anna Barón; Molly M Lamb; Tessa L Crume; Marci K Sontag; Marian Rewers; Jill M Norris
Journal:  Biomed Res Int       Date:  2015-03-25       Impact factor: 3.411

4.  HLA-DRB1*03 as a risk factor for microalbuminuria in same duration of type 1 diabetes: a case control study.

Authors:  Dovilė Ražanskaitė-Virbickienė; Evalda Danytė; Rimantas Žalinkevičius
Journal:  BMC Nephrol       Date:  2016-03-31       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.